2Bodner, LM, Wisner, KL. Implications for improving mental health among childbearing-aged women. Biological Psychiatry 2005; 58: 679–685.
3Reynolds, EH, Preece, JM, Bailey, J, Coppen, A. Folate deficiency in depressive illness. British Journal of Psychiatry 1970; 117: 287–292.
4Carney, MWP, Chary, TKN, Laundy, M, Bottiglieri, T, Chanarin, I, Reynolds, EH, et al. . Red cell folate concentrations in psychiatric patients. Journal of Affective Disorders 1990; 19: 207–213.
5Ghadirian, AM, Anath, J, Engelsmann, F. Folic acid deficiency in depression. Psychosomatics 1980; 21: 926–929.
6Abouh-Saleh, MT, Coppen, A. Serum and red blood cell folate in depression. Acta Psychiatrica Scandinavica 1989; 80: 78–82.
7Coppen, A, Abouh-Saleh, MT. Plasma folate and affective morbidity during long-term lithium therapy. British Journal of Psychiatry 1982; 141: 87–89.
8Botez, MI, Botez, T, Levielle, J, Biellmann, P, Cadotte, M. Neuropsychological correlates of folic acid deficiency: facts and hypotheses. In: Botez, MI, Reynolds, EH, eds. Folic Acid in Neurology, Psychiatry, and Internal Medicine. New York: Raven Press, 1979; 425–461.
9Guaraldi, G, Fava, M, Mazzi, F, LaGreca, P. An open trial of methyltetrahydrofolate (MTHF) in elderly depressed patients. Annals of Clinical Psychiatry 1993; 5: 101.
10Fava, M, Borus, JS, Alpert, JE, Nierenberg, AA, Rosenbaum, JF, Bottiglieri, T. Folate, vitamin B12, and homocysteine in major depressive disorder. American Journal of Psychiatry 1997; 154: 426–428.
11Wald, DS, Law, M, Morris, JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. British Medical Journal 2002; 325: 1202–1209.
12Reynolds, EH, Carney, MWP. Methylation and mood. Lancet 1984; 2: 196–198.
13Cantoni, GL. S-adenosylmethionine: a new intermediate formed enzymatically from l-methionine and adenosine triphosphate. Journal of Biological Chemistry 1953; 204: 403–416.
14Bottiglieri, T, Hyland, K, Reynolds, EH. The clinical potential of ademethionine (S-adenosylmethionine) in neurological disorders. Drugs 1994; 48: 137–152.
15Ordonez, LA, Wurtman, RJ. Folic acid deficiency and methyl group metabolism in rat brain: effects of l-Dopa. Archives of Biochemistry and Biophysics 1974; 160: 372–376.
16Agnoli, A, Ruggieri, S, Cerrone, GG. The dopamine hypotheses of depression: results of treatment with dopaminergic drugs. In: Grattini, S, ed. Depressive Disorders. Stuttgart: FK Schatauer Verlag, 1977; 447–458.
17Lapin, IP, Oxenkrug, GF. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969; 1: 132–136.
18Le Quan-Bui, KH, Plaisant, O, Leboyer, M, Gay, C, Kamal, L, Devynck, M, et al. . Reduced platelet serotonin in depression. Psychiatry Research 1984; 13: 129–139.
19Quintana, J. Platelet serotonin and plasma tryptophan in endogenous depression. Clinical, therapeutic, and biological correlations. Journal of Affective Disorders 1992; 24: 55–62.
20Coppen, AP, Turner, P, Rowsell, AR, Padgham, C. 5-Hydroxytryptamine (5-HT) in the whole blood of patients with depressive illness. Postgraduate Medical Journal 1956; 52: 156–158.
21Botez, MI, Young, SN, Bachevalier, J, Gauthier, S. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxindoleacetic acid in human cerebrospinal fluid. Annals of Neurology 1982; 12: 479–484.
22Brattstrom, L, Israellson, B, Jeppson, J, Hultberg, B. Folic acid – an innocuous means to reduce plasma homocysteine. Scandinavian Journal of Clinical and Laboratory Investigation 1998; 48: 215–221.
23Bottiglieri, T. Homocysteine and folate metabolism in depression. Progress in Neuro-psychopharmacology and Biological Psychiatry 2005; 29: 1103–1112.
24Homocysteine Lowering Trialists Collaboration. Dose dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. American Journal of Clinical Nutrition 2005; 82: 806–812.
25Frosst, P, Blom, HJ, Milos, R, Goyette, P, Sheppard, CA, Mathews, RG, et al. . A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111–113.
26Molloy, AM, Daly, S, Mills, JL, Kirke, PN, Whitehead, AS, Ramsbottom, D, et al. . Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349: 1591–1593.
27Lewis, SJ, Lawlor, DA, Smith, GD, Araya, R, Timpson, N, Day, INM, et al. . The thermolabile variant of MTHFR is associated with depression in the British Women’s Heart and Health Study and a meta-analysis. Molecular Psychiatry 2006; 11: 352–360.
28Bjelland, I, Tell, GS, Vollset, SE, Refsum, H, Ueland, PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C–T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Archives of General Psychiatry 2003; 60: 618–626.
29Bottiglieri, T, Laundy, M, Crellin, R, Toone, BK. Homocysteine, folate, methylation, and monoamine metabolism in depression. Journal of Neurology and Psychiatry 2000; 69: 228–234.
30Cassidy, K, Kotynia-English, R, Acres, J, Flicker, L, Lautenschlager, NT, Almeida, OP. Association between lifestyle factors and mental health measures among community-dwelling older women. Australian and New Zealand Journal of Psychiatry 2004; 38: 940–947.
31Bryan, J, Calvaresi, E, Hughes, D. Short-term folate, vitamin B12 or vitamin B6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition 2002; 132: 1345–1356.
32Williams, E, Stewart-Knox, B, Bradbury, I, Rowland, I, Pentieva, K, Helander, A, et al. . Effect of folic acid supplementation and serotonin response in healthy males. British Journal of Nutrition 2005; 94: 602–608.
33Molloy, AM, Scott, JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods in Enzymology 1997; 281: 43–53.
34Almeida, OP, Flicker, L, Lautenschlager, NT, Leedman, P, Vasikaran, S, van Bockxmeer, FM. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiology of Aging 2005; 26: 251–257.
35Office for National Statistics. The National Statistics Socio-Economic Classification User Manual. London: HMSO, 2002.
36Farber, ML. Time perspective and feeling tone a study in perception of the day. Journal of Psychology 1953; 35: 253–257.
37Larsen, RJ, Kasimatis, M. Individual differences in entrainment of mood to the weekly calendar. Journal of Personality and Social Psychology 1990; 58: 164–171.
38Leino, A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx Analyzer. Clinical Chemistry 1999; 45: 569–571.
39Watson, D, Clark, LA, Tellegen, A. Development and validation of brief measures of positive and negative affect: the PANAS scales. Journal of Personality and Social Psychology 1988; 54: 1063–1070.
40Watson, D. Mood and Temperament. New York: The Guilford Press, 2000.
41Williams, E, Stewart-Knox, B, Helander, A, McConville, C, Bradbury, I, Rowland, I. Associations between whole-blood serotonin and subjective mood in healthy male volunteers. Biological Psychology 2005; 71: 171–174.
42Duffy, ME, Stewart-Knox, BJ, McConville, C, Bradbury, I, O’Connor, J, Helander, A, et al. . The relationship between whole-blood serotonin and subjective mood in apparently healthy postmenopausal women. Biological Psychology 2006; 73: 165–168.
43Nunnally, JC. Psychometric Theory, 2nd ed. New Delhi: McGraw Hill Ltd, 1981.
44Reynolds, EH, Preece, J, Johnson, AL. Folate metabolism in epileptic and psychiatric patients. Journal of Neurology and Psychiatry 1971; 34: 726–732.
45Godfrey, PSA, Toone, BK, Carney, MWP, Flynn, TG, Bottiglieri, T, Laundy, M, et al. . Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336: 392–395.
46McConville, C. Personality, motivational and situational influences on mood variability. Doctoral thesis, University of Ulster, Northern Ireland, 1992.
47Costello, J, Benjamin, R, Angold, A, Silver, D. Mood variability in adolescents. A study of depressed, nondepressed and comorbid patients. Journal of Affective Disorders 1991; 23: 199–212.
48McConville, C, Cooper, C. Mood variability and the intensity of depressive states. Current Psychology 1996; 14: 329–338.
49Beck, AT, Ward, CH, Mendelsohn, M, Mock, J, Erbaugh, J. An inventory for measuring depression. Archives of General Psychiatry 1961; 4: 561–571.
50Lubin, B. Depression Adjective Checklist. San Diego, CA: Educational and Industrial Testing Service, 1981.
51Tellegen, A. Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report. In: Tuma, AH, Maser, JD, eds. Anxiety and the Anxiety Disorders. Hillside, NJ: Erlbaum, 1985; 681–706.
52Sauberlich, HE. Relationship of vitamin B-6, vitamin B-12, and folate to neurological and neuropsychiatric disorders. In: Bendich, A, Butterworth, C, eds. Micronutrients in Health and Disease Prevention. New York: Marcel Dekker, 1991: 187–218.
53Scientific Advisory Committee on Nutrition (SACN). Draft Report for Consultation: Folate and Disease Prevention. London: SACN, November 2005.
54Wald, N. Prevention of neural tube defects – results of the Medical Research Council vitamin study. Lancet 1991; 338: 131–137.